GlassScriptPhysician profile
Matthew J Mlot
NPI 1093728883
$488.22
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.06 · 2020: $110 · 2021: $268 · 2022: $95.69.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $150.47 | 2020-2021 | |
| Abbvie INC. | $106.29 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $100.32 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.74 | 2021 | |
| Pfizer INC. | $32.51 | 2022 | |
| Intercept Pharmaceuticals, INC. | $25.18 | 2019-2020 | |
| Janssen Biotech, INC. | $14.85 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.86 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mlot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.